Belite Bio Q3 EPS $(0.65) Misses $(0.45) Estimate
Benzinga Newsdesk 12 months ago
EarningsEarnings MissesNews
Belite Bio (NASDAQ:BLTE) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.45) by 44.44 percent. This is a 132.14 percent decrease over losses of $(0.28) per share from the
Belite Bio (NASDAQ:BLTE) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.45) by 44.44 percent. This is a 132.14 percent decrease over losses of $(0.28) per share from the same period last year.